生长抑素及蛋白酶抑制剂用于预防ERCP术后胰腺炎及高淀粉酶血症的贝叶斯网状Meta分析(7)
[30] UEKI T， OTANI K， KAWAMOTO K， et al. Comparison between ulinastatin and gabexate mesylate for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis： a prospective， randomized trial[J]. J Gastroenterol， 2007， 42(2)：161-167.
[31] FUJISHIRO H， ADACHI K， IMAOKA T， et al. Ulinastatin shows preventive effect on post-endoscopic retrograde cholangiopancreatography pancreatitis in a multicenter prospective randomized study[J]. Eur J Gastroenterol Hepatol， 2006， 21(6)：1065-1069.
, http://www.100md.com
[32] XIONG GS， WU SM， ZHANG XW， et al. Clinical trial of gabexate in the prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis[J]. Braz J Med Biol Res， 2006， 39(1)：85-90.
[33] TSUJINO T， KOMATSU Y， ISAYAMA H， et al. Ulinastatin for pancreatitis after endoscopic retrograde cholangiopancreatography： a randomized， controlled trial[J]. Clin Gastroenterol Hepatol， 2005， 3(4)：376-383.
[34] ANDRIULLI A， SOLMI L， LOPERFIDO S， et al. Prophylaxis of ERCP-related pancreatitis： a randomized， controlled trial of somatostatin and gabexate mesylate 1[J]. Clin Gastroenterol Hepatol， 2004， 2(8)：713-718.
, http://www.100md.com
[35] ARVANITIDIS D，ANAGNOSTOPOULOS GK，GIAN- NOPOULOS D， et al. Can somatostatin prevent post- ERCP pancreatitis？Results of a randomized controlled trial[J]. J Gastroenterol Hepatol， 2004， 19(3)：278-282.
[36] POON RT， YEUNG C， LIU CL， et al. Intravenous bolus somatostatin after diagnostic cholangiopancreatography reduces the incidence of pancreatitis associated with therapeutic endoscopic retrograde cholangiopancreatography procedures： a randomised controlled trial[J]. Gut， 2003， 52(12)：1768-1773.
, http://www.100md.com
[37] ANDRIULLI A， CLEMENTE R， SOLMI L， et al. Gabexate or somatostatin administration before ERCP in patients at high risk for post-ERCP pancreatitis： a multicenter， placebo-controlled， randomized clinical trial[J]. Gastrointest Endosc， 2002， 56(4)：488-495.
[38] POON RT， YEUNG C， LO CM， et al. Prophylactic effect of somatostatin on post-ERCP pancreatitis： a randomized controlled trial[J].Gastrointest Endosc，1999，49(5)： 593-598.
, 百拇医药 [39] CAVALLINI G， TITTOBELLO A， FRULLONI L， et al. Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. Gabexate in digestive endoscopy：Italian group[J]. N Engl J Med，1996，335(13)：919-923.
[40] PERSSON B， SLEZAK P， EFENDIC S， et al. Can somatostatin prevent injection pancreatitis after ERCP？[J]. Hepatogastroenterology， 1992， 39(3)：259-261., 百拇医药(陈健刚 张丹丹 吕旭峰 杨悦)
[31] FUJISHIRO H， ADACHI K， IMAOKA T， et al. Ulinastatin shows preventive effect on post-endoscopic retrograde cholangiopancreatography pancreatitis in a multicenter prospective randomized study[J]. Eur J Gastroenterol Hepatol， 2006， 21(6)：1065-1069.
, http://www.100md.com
[32] XIONG GS， WU SM， ZHANG XW， et al. Clinical trial of gabexate in the prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis[J]. Braz J Med Biol Res， 2006， 39(1)：85-90.
[33] TSUJINO T， KOMATSU Y， ISAYAMA H， et al. Ulinastatin for pancreatitis after endoscopic retrograde cholangiopancreatography： a randomized， controlled trial[J]. Clin Gastroenterol Hepatol， 2005， 3(4)：376-383.
[34] ANDRIULLI A， SOLMI L， LOPERFIDO S， et al. Prophylaxis of ERCP-related pancreatitis： a randomized， controlled trial of somatostatin and gabexate mesylate 1[J]. Clin Gastroenterol Hepatol， 2004， 2(8)：713-718.
, http://www.100md.com
[35] ARVANITIDIS D，ANAGNOSTOPOULOS GK，GIAN- NOPOULOS D， et al. Can somatostatin prevent post- ERCP pancreatitis？Results of a randomized controlled trial[J]. J Gastroenterol Hepatol， 2004， 19(3)：278-282.
[36] POON RT， YEUNG C， LIU CL， et al. Intravenous bolus somatostatin after diagnostic cholangiopancreatography reduces the incidence of pancreatitis associated with therapeutic endoscopic retrograde cholangiopancreatography procedures： a randomised controlled trial[J]. Gut， 2003， 52(12)：1768-1773.
, http://www.100md.com
[37] ANDRIULLI A， CLEMENTE R， SOLMI L， et al. Gabexate or somatostatin administration before ERCP in patients at high risk for post-ERCP pancreatitis： a multicenter， placebo-controlled， randomized clinical trial[J]. Gastrointest Endosc， 2002， 56(4)：488-495.
[38] POON RT， YEUNG C， LO CM， et al. Prophylactic effect of somatostatin on post-ERCP pancreatitis： a randomized controlled trial[J].Gastrointest Endosc，1999，49(5)： 593-598.
, 百拇医药 [39] CAVALLINI G， TITTOBELLO A， FRULLONI L， et al. Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. Gabexate in digestive endoscopy：Italian group[J]. N Engl J Med，1996，335(13)：919-923.
[40] PERSSON B， SLEZAK P， EFENDIC S， et al. Can somatostatin prevent injection pancreatitis after ERCP？[J]. Hepatogastroenterology， 1992， 39(3)：259-261., 百拇医药(陈健刚 张丹丹 吕旭峰 杨悦)